Lux Capital

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Biotech · Jul 27, 2026

Lux Capital invests in companies emerging from the life sciences, physical sciences and computational sciences, including biotechnology, robotics, aerospace, defence and AI infrastructure.

Its investment approach includes small Seeds, Experiments and Optionality investments that let it engage with technology before a conventional venture case is established. The firm also makes thesis-driven investments and backs founders working on technically difficult problems.

Lux’s Riskgaming programme uses researched scenarios to examine how technological developments interact with geopolitics and national security. That perspective is especially relevant for founders whose commercial opportunity depends on scientific progress, industrial adoption or government demand.

Sources
Rounds participated in
4
Confirmed lead rounds
0
1 roles undisclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$751M
4 disclosed · full round size, not this investor’s share

By stage

Seed2
Series A1
Series C+1

By primary sector

Biotech3
Defense tech1

By country

United States4

Rounds

4 in this selection
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A
Participant
Warhound

Warhound develops working dogs for military, law-enforcement and emergency-response teams.

$200MSeed
Participant
Enveda

Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.

$311MSeries E
Participant
Transfyr

Physical AI platform capturing real-world lab science into machine-readable data

$25MSeed
Role not disclosed